Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$25.43 +0.08 (+0.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Cash from Operations (2013 - 2026)

Updated

Amphastar Pharmaceuticals (AMPH) reported Cash from Operations of $51.32 million for Q2 2026, up 44.2% from $35.59 million a year earlier and up 7.3% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Cash from Operations (2013 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Amphastar Pharmaceuticals' Cash from Operations came in at $184.61 million, up 15.6% year-over-year; for FY2025, it came in at $156.12 million, down 26.8% from FY2024.

  • Cash from Operations has a five-year compound annual growth rate of 22.2% (FY2020 to FY2025).
  • By year, Cash from Operations came in at $213.39 million in FY2024 (+16.3%), $183.5 million in FY2023 (+105.8%), $89.18 million in FY2022 (-9.0%) and $97.99 million in FY2021 (+71.1%).
  • Five-year quarterly Cash from Operations spans a low of $2.57 million in Q3 2021 and a high of $69.11 million in Q2 2024.
  • Year over year, Cash from Operations has now increased in each of the last three quarters, with growth averaging 1.4% over the last eight quarters.
  • The high point for year-over-year Cash from Operations in five years was Q3 2022 (growth of 693.1%); the low point was Q2 2022 (a decline of 91.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $47.84 million (Q1 2026), $32.86 million (Q4 2025) and $52.58 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.62 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.44 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.58 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.57 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 835.00 Mn
10 Amphastar Pharmaceuticals 1.08 Bn -59.50 Mn 93.47 Mn 51.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.32 Mn
Mar 31, 2026 47.84 Mn
Dec 31, 2025 32.86 Mn
Sep 30, 2025 52.58 Mn
Jun 30, 2025 35.59 Mn
Mar 31, 2025 35.08 Mn
Dec 31, 2024 29.02 Mn
Sep 30, 2024 59.96 Mn
Jun 30, 2024 69.11 Mn
Mar 31, 2024 55.29 Mn
Dec 31, 2023 23.86 Mn
Sep 30, 2023 64.33 Mn
Jun 30, 2023 54.92 Mn
Mar 31, 2023 40.38 Mn
Dec 31, 2022 15.23 Mn
Sep 30, 2022 20.38 Mn
Jun 30, 2022 2.82 Mn
Mar 31, 2022 50.77 Mn
Dec 31, 2021 40.44 Mn
Sep 30, 2021 2.57 Mn
API Access

Amphastar Pharmaceuticals Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=AMPH&period=max&api_key=YOUR_API_KEY